ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,048.65
0.60%
US Tech 100
16,993.60
0.79%
다우존스 지수
38,121.78
0.58%
Bitcoin
59,153.73
1.57%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. ARS Pharmaceuticals Inc (SPRY)

  7. ARS Pharmaceuticals Inc (SPRY) 뉴스

SPRY ARS Pharmaceuticals Inc

9.21
-0.12 (-1.29%)
최종 업데이트: 02:04:08
15분 지연
기업명 주식 심볼 시장 주식 타입
ARS Pharmaceuticals Inc SPRY 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.12 -1.29% 9.21 02:04:08
개장가 저가 고가 종가 전일 종가
9.35 8.94 9.4909 9.33
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202422:01GLOBEARS Pharmaceuticals Submits Response for neffy® (epinephrine..
03/04/202422:01GLOBEARS Pharmaceuticals Submits Response to FDA Complete..
22/03/202405:05GLOBEARS Pharmaceuticals Provides Business Update and Reports..
08/03/202406:05GLOBEARS Pharmaceuticals Reviews Recent Clinical Updates and..
08/03/202402:56EDGAR2Form 8-K - Current report
06/03/202423:01GLOBEARS Pharmaceuticals to Participate in the Leerink Partners..
02/03/202410:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202411:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202402:08EDGAR2Form 144 - Report of proposed sale of securities
26/02/202423:01GLOBEARS Pharmaceuticals announces neffy® meets primary endpoints..
22/02/202423:01GLOBEARS Pharmaceuticals to Host Virtual neffy® Investor Day on..
20/02/202423:01GLOBEARS Pharma Announces Favorable Topline Results from Repeat..
05/02/202423:01GLOBEARS Pharmaceuticals to Present Positive Clinical Efficacy..
05/01/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202306:02EDGAR2Form 8-K - Current report
10/11/202306:00GLOBEARS Pharmaceuticals Reports Third Quarter 2023 Financial..
10/11/202301:02GLOBEARS Pharmaceuticals Announces Presentation of Clinical Data..
06/10/202322:57DJNARS Pharmaceuticals to Meet With FDA on Neffy Rejection
06/10/202322:03GLOBEARS Pharmaceuticals Announces Scheduling of a Type A Meeting..
03/10/202322:03GLOBESingle and Repeat Dose Clinical Study of neffy (epinephrine..
26/09/202305:17EDGAR2Form 8-K - Current report
20/09/202323:20DJNARS Pharmaceuticals Shares Sink to New Lows on FDA Neffy..
20/09/202319:30DJNARS Pharmaceuticals Shares Sink Premarket as FDA Rejects..
20/09/202319:05EDGAR2Form 8-K - Current report
20/09/202311:49GLOBEFDA Issues Complete Response Letter for neffy® (epinephrine..
02/09/202305:15EDGAR2Form SC 13D/A - General statement of acquisition of..
11/08/202305:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:05EDGAR2Form 8-K - Current report
11/08/202305:00GLOBEARS Reports Second Quarter 2023 Financial Results and..
29/06/202310:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/06/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/06/202305:32EDGAR2Form 8-K - Current report
20/06/202321:00GLOBEARS Pharmaceuticals Announces PDUFA Date Extension for..
15/05/202322:00GLOBEARS Pharmaceuticals Highlights Progress and Reports First..
12/05/202321:55DJNARS Pharmaceuticals Soar 68% in Premarket Trading as FDA..
12/05/202308:01GLOBEFDA Advisory Committee Votes in Support of Favorable..
09/05/202322:10GLOBEARS Pharmaceuticals Announces Availability of Briefing..

최근 히스토리

NASDAQ
SPRY
ARS Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유